Treatment of a clinically determined lower-risk stage III non-lymphoblastic non-Hodgkin lymphoma with less intensive therapy does not impact negatively on outcome
- Asim F. Belgaumi
- , Lobna Shalaby
- , Amani Al-Kofide
- , M. Ashraf Chaudhary
- , Christopher Alviedo
- , Rajeh Sabbah
Research output: Contribution to journal › Article › peer-review
3
Citations
(Scopus)